Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology > Antipsychotics > Flashcards

Antipsychotics Flashcards

1
Q

Paranoid schizophrenia

A

one or more delusions or frequent auditory hallucinations, someone is trying to “get them” hurt them, steal from them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Disorganized schizophrenia

A

speech and behavior oriented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Catatonic schizophrenia

A

stupor, posturing, mutism, fetal position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Residual

A

absence of prominent sx but evidence of illness and functional impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiology of schizophrenia

A

prevalence remarkably similar among most cultures, most common in late adolescence or early adulthood, prevalence in males and females, lifetime prevalence of .6-1.9%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Etiology of schizophrenia

A

abnormalities in brain structure an dysfunction, changes not consistent among all individuals, multifactorial causes, neurodevelopmental model, utero disturbance, schizophrenic lesions, genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Positive symptoms

A

hallucinations, delusions, false beliefs, disorganized speech, cannot follow train of thought, psychomotor agitation, bizarre behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Negative symptoms

A

alogia-poverty of speech, brief responses, lack of thought; flattened affect, avolition- lack in self initiated goal-directed activity, socially isolated; anhedonia- lack of interest and motivation in other people/activities, attentional impairment- psychomotor slowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical course

A

onset (acute/gradual), acute stabilization, stabilization, maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

approaches to therapy

A

individual- supportive/ counseling, personal therapy, social skills therapies, rehab; group- interactive/ social, cognitive behavioral- cog behavior therapy, compliance therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA of treating schizo

A

blockade of DA receptors in mesolimbic area, D2 blockade- affinity for this receptor accounts for antipsychotic activity, D1 blockade- partially responsible for antipsychotic activity, responsible for EPS sx, 5HT blockade- improve neg sx and motor ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Receptor activity

A

D1-D5: relief of psychosis, EPS; 5HT2: helps suppress DA activity, protect from EPS, wt gain; a1: orhto hypo, dizziness, M1: ACh ADRs, may protect against EPS, drowsiness, dry mouth, blurred vision, constipation, H1: wt gain, drowsiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Popular atypical antipsychotics

A

Quetiapine (Seroquel), Risperidone (Risperdal), ziprasidone (Geodon), Olanzapine (Zyprexa), Aripiprazole (Abilify)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nausea and vomiting typical antipsychotics

A

Prochlorperazine (Compazine), Chlopromazine (Thorazine), Droperidol (Inapsine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antipsychotics typical

A

Haloperidol (Haldol), Thioridazine (Mellaril), Thiothixene (Navane), Loxapine (Loxitane), Perphenazine (Trilafon), Fluphenazine (Prolixin), Trifluoperazine (Stelazine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Typical antipsychotic pearls

A

all have equal efficacy, MOA- non-selective blockade of D2 receptors, effective at treating positive sx, major concern is EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Haloperidol (Haldol) dosing forms

A

Available IM or PO, IM-fast acting, also available as Depot shot, given once monthly, IVP is linked to increased risk of arrythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Haloperidol (Haldol) Pearls

A

drug of choice for ICU psychosis, used occasionally for CI for EtOH withdrawals, watch for QTc prolongation, higher potensity for EPS and anticholinergic ADRs, many DI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chlorpromazine (Thorazine)

A

available PO or IM (IM used in peds for acute mania), off label- retractable hiccups (DOC), migraines, also used for N/V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Droperidol (Inapsine)

A

N/V migraines, major concern being proarrhythmic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ADRs or antipsychotics

A

sedation, ACh- dry mouth, constipation, blurry vision, antiadrenergic- orthstatic hypotension, wt gain, prolongation of QT interval, inc prolactin secretion (menstrual changes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

EPS

A

related to blockade of D1 receptor in substantia nigra, reversible if discovered early, associated w/ all typicals and some atypicals, includes- dystonia, pseudoparkinsonism, akathisia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prolonged QT

A

typicals increase Qt interval, inc risk of torsades/ ventricular arrythmia, medications- typical antipsychotics, antibiotics, antifungals, low mag/K, CHF, renal/ hepatic d, CVA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of Acute dystonia

A

diphenhydramine (Benadryl), benztropine (Cogentin), must be given right away for quick reversal, usually IV, follow w/ PO agent x 1-2 wks to prevent recurrence, will worsen tardive dyskinsias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
EPS- pseudoparkinsonism
20-40%, happens within several months, because of DA blockade causing relative imbalance of DA and ACh, increased risk w/ use of typicals and high risperidone high dose
26
Treatment ppseuodparkinsonism
decrease dose, change med, anticholinergics, amantadine to block DA
27
Tardive dyskinesia
occurs in 10-20% of pts, not EPS, associated w/ chronic use, often irreversible, high risk w/ typicals, elderly and women
28
Tardive dyskinesia presentation
largely orofacial, involuntary movements of face, neck, back, trunk and extremities, blinking, lip smacking, starts as tongue protrusion w/ appearance of lip smacking and difficulty speaking, chewing and swollowing
29
Tardive dyskinesia treatment
can be controlled if pt concentrates, limited to duration and dose of drug, often occurs when drug is decreased, no effective drug therapy, inc dose back to where it was, ACh make worse
30
Neuroleptic malignant syndrome
due to blockade of DA receptors, typicals have highest risk, Medical Emergency, 5-20% fatality,, mean age 40, higher risk in pts w/ mood disorders, lithium use, 1/3 cases develop subsequent NMS if re-chanllenged
31
NMS diagnosis
tx w/ AP w/in 7 days of onset, hyperthermia >100.4, muscle rigidity, 5 of following- changed in mental status, tachy myoglobinuria, inc WBC, tremor, tachypnea, incontinence, CPK inc, metabolic acidosis, labile BP
32
NMS TX
dec risk factors, early recognition, stop offending agent, supportive care, Dantrolene (Dantrium), amantadine, bromocriptine, lorazepam, may have to sedate, intubate and paralyze
33
Atypical antipsychotics
Clozapine, risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole, paloperidone, asenapine, iloperidone, lurasidone
34
Atypical antipsychiotics MOA
D2 and 5HT antagonists, 5HT is an inhibitory neurotransmitter, mesolimbic selectvely for D2 blockage, 5HT has minimal effects on prolactin, dec EPS, beneficial on neg sx
35
Clozapine (Clozaril)
first atypical, no EPS, TD or effect on prolactin, slow dose titration due to dec BP, strict monitoring for WBS
36
Clozapine (Clozaril) use
considered to be most efficacious, only for pts who have failed other agents, most potent for tx of pos and neg sx, good for pt w/ hx of suicide, substance abuse, last line, avoid in combo w/ benzos
37
Clozapine agranulocytosis
occurs in 3%, requires monitoring once weekly for 6 months, biweekly for next 6 months and once a month after, do not initiate if WBC 600 mg/d
38
Risperidone (Risperdal)
EPS dose related (>6mg/d) low dose good for geriatric agitation, not as effective for treating neg sx
39
Clozapine ADRs
hypersalivation, wt gain, dec bp, sig sedation, seizures if >600 mg/d
40
Risperidone dose and ADRs
.5 mg PO BID up to 3 mg PO BID, elevated LFTs, hyperprolactinemia, orthostasis, sexual dysfunction, sedation, wt gain,
41
Risperdal CONsta
IM injection q 2 weeks, must be overlapped w/ oral therapy upon initiation
42
Olanzapine (Zyprexa)
similar to Clozaril, no EPS, low TD, also used for acute agitation, bipolar maintenance, acute mania
43
Olanzapine ADRs and dose
20-60 mg PO QHS, significant sedation, wt gain, diabetes risk, low BP, no agranulocytosis, IM injection- short term treatment of acute agitation, at least as effective as Haldol, w/ quicker onset and lower incidence of dystonia and EPS
44
Quetiapine (Seroquel)
Low risk EPS, low TD, can see addiction
45
Quetiapine ADRs and dose
Sedation, mild hypo, wt gain, HA, cataracts in animals, 50-300 mg PO qHS, low doses used for anxiety, insomnia, depression
46
Ziprasidone (Geodon)
Oral IM, 20-40 mg PO BID, IM favored by many for acute mania, acute agitation IM q 2 hrs prn, ADRs-prolonged QT, mild sedatioin, minimal wt gain, EPS- low, TD low
47
Aripiprazole (Abilify) MOA
da modulator, only works when needs to, partially blocks D2 receptor when DA is inc, activate D2 receptor when DA is dec, 5HT2 antagonists improves efficacy for neg sx; often used in peds
48
Aropiprazole Adrs, dose
little wt gain, inc prolactin levels, possible diabetes, anxiety insomnia, HA, nausea, vomiting, low incidence EPS, no TD, no QT, least low BP; 5-15 mg PO Daily
49
Paliperidone (Invega)
active metabolite of risperidone, once daily, PO, less risk EPS and prolactin inc, niche- pts w/ liver disease, ADR- sedation, low BP
50
Iloperidone (Fanapt)
schizo only, Qt prolongation, avoid in arrhythmias
51
Luprasidone (Latuda)
schizo only, no Qt prolongation, $$$, not 1st line
52
Asenapine (Saphris)
D2 antagonist, 5 HT2A antagonist, SL only
53
Meatabolic syndrome
consider when starting therapy, do baseline screenings and regular monitoring, get good fam hx
54
Transitioning
taper over 1-2 weeks to prevent w/ drawal, Risperidone- overlap oral and IM by 3 weeks, haloperidol- overlap oral and IM by 1 month
55
Augmentation therapy for schizo
Benzos- lorazepam for agitaton and aggression, BB (aggression), mood stabilizers- improves aggitation, lithium, anticonvulsants (carbamazepine, valproate, gabapentin, topiramate), SSRI w/ 1st generation OCD
56
General principals for APs
therapeutic trial for 6 weeks, (Clozapine needs 12), duration of tx- initial diagnosis (1-2 years) then reassess if relapse treat 5yrs-life, polypharm- consider clozapine before combo, not recommended unless failed others
57
Compliance
#1 reason for relapse, cog fun may be lower, lack of understanding, stigma, cost is little concern
58
Summary of APs
considered 1st line, effectively treats all psychotic sx, enhanced tolerability, improved cog effects, better outcome in long-term, reduced rate of relapse and hospitalization
59
Summary of TPs
not usually 1st line, inc risk of EPS/ TD, not as effective in treating neg sx, not likely to improve cog func, no more effective in treating pos sx
60
Summary of compiance and duration of Tx
chronic disorder requiring life-long tx, tx after 1st episode continued for at least one year, nonadherence to meds is a complicated and signif issue, up to 70% of pts relapse w/in 1st 12 months if not taking maintenance meds

Pharmacology (61 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions